Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Nevis Brands Inc
C.NEVI
Alternate Symbol(s):
NEVIF
Healthcare
Cannabis
Nevis Brands Inc., formerly Pascal Biosciences Inc., provides cannabis brands throughout the United States. The Company provides products in Washington, Oregon, California, Ohio, Arizona and Colorado through partners and licensees. Its products include the flagship brand Major, which is a cannabis beverage. Major is a high-dose tetrahydrocannabinol (THC) beverage that delivers a consistent...
cannabis experience with no cannabis taste or smell. Major offers various flavors, such as volcanic orange mango, sunset pink lemonade, Pacific Coast blue raspberry, dreamin' of passion, and sacred grape. It also offers Major Minis, which is a smaller 2 ounce (oz) shot. Major Minis come in three flavors, such as blueberry, fruit punch, and blackberry lemonade. The Company has introduced Major Mojo-Rita and Sugar-Free Ginger-ade in Washington and Major Sugar-Free Lemonade and Apple Peach in Missouri.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (CSE:NEVI)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(2)
•••
Pascalbios
X
View Profile
View Bullboard History
Comment by
Pascalbios
on Apr 30, 2021 3:41pm
RE:Yesssss! $$$$🚀🚀 PAS Look at this one now!!! 0.35¢ 🚀🚀 $$$
Anonymous is buying a lot of stocks and will sell at 0.35 ¢ minimum or 0.40 ¢ on the next big news according to technical analysts. Recent Trades - All 7 today
...more
(3)
•••
BayouEmpire
X
View Profile
View Bullboard History
Post by
BayouEmpire
on Apr 30, 2021 3:27pm
Up, up
Everybody by before the lift off!!!! only 160k before .0175$!!!! Only 340500 shares before .30 $ and only 478k shares before .40$ good newsssss
Voyageur Signs Letter of Intent with Large Multinational Pharmaceutical Company
posted Dec 22, 2024 9:00am by
Voyageur Pharmaceuticals Ltd
-
|
Voyageur is securing supply chains in North America for barium, iodine and fullerene drug development and is aiming to gain efficiencies in production of contrast media products. The company anticipates this LOI will expand Voyageur’s project portfolio and diversify the Company’s product mix. The global contrast media market is valued at $6.3 billion with GE HealthCare projecting it will double over the next decade. ...read more
(2)
•••
Pascalbios
X
View Profile
View Bullboard History
Post by
Pascalbios
on Apr 30, 2021 9:09am
> SEDAR financial statements < $$$$$$$$$$$$$$$$$$$$$$$$$$$$$
https://www.stockwatch.com/News/Sedardoc/4818779.pdf https://www.stockwatch.com/News/Sedardoc/4818780.pdf
(3)
•••
BayouEmpire
X
View Profile
View Bullboard History
Post by
BayouEmpire
on Apr 29, 2021 5:24pm
Load
Its time To load your wallet before the lift To 0.35$!!! Up,Up!
(3)
•••
Kani0ikan123456
X
View Profile
View Bullboard History
Comment by
Kani0ikan123456
on Apr 27, 2021 11:24am
RE:🚀🚀 PAS Look at this one now!!! 0.085¢ 🚀🚀
Wow! Trust you are well rewarded! May your balance go to the moon and then to Mars! Wow! Imagine what change in SP you will get with 0 (zero) volume....to Mars!
(2)
•••
Pascalbios
X
View Profile
View Bullboard History
Post by
Pascalbios
on Apr 27, 2021 9:25am
>>>>>>>>>>>>> PAS open at 0.085¢ <<<<<<<<<<<<<<<<<
V:PAS - PASCAL BIOSCIENCES INC - https://www.pascalbiosciences.com 09:23:30 EDT Live Quote Sym-X Bid - Ask Last Chg
...more
(2)
•••
Pascalbios
X
View Profile
View Bullboard History
Post by
Pascalbios
on Apr 27, 2021 8:35am
> Pascal Biosciences Announces Management Changes <
Pascal Biosciences Inc. (“Pascal” or the “Company”) (TSXV:PAS) (OTC:BIMUF), a biotechnology company that specializes in cancer, cannabinoids, and Covid-19 is announcing several management changes
...more
(2)
•••
Pascalbios
X
View Profile
View Bullboard History
Post by
Pascalbios
on Apr 27, 2021 8:33am
Pascal Biosciences Confirms Specific Cannabinoids Combat Cor
Pascal Biosciences Confirms Specific Cannabinoids Combat Coronavirus Pascal Biosciences Inc. (TSX.V:PAS) (OTC:BIMUF) (“Pascal” or the “Company”) today announced the Company has confirmed an earlier
...more
(2)
•••
Pascalbios
X
View Profile
View Bullboard History
Post by
Pascalbios
on Apr 26, 2021 10:29am
PASCAL BIOSCIENCES CONFIRMS SPECIFIC CANNABINOIDS COMBAT COR
Pascal Biosciences Inc. (TSXV:PAS)(OTC PINK:BIMUF) ("Pascal" or the "Company") today announced the Company has confirmed an earlier report that certain cannabinoids block
...more
(2)
•••
Pascalbios
X
View Profile
View Bullboard History
Post by
Pascalbios
on Apr 26, 2021 10:26am
PASCAL BIOSCIENCES AND S?RSE TECHNOLOGY OPTIMIZE CANNABINOID
Pascal Biosciences Inc. (TSXV:PAS)(OTC PINK:BIMUF) ("Pascal" or the "Company") and SRSE Technology Corporation ("SRSE") have validated and optimized a formula for oral
...more
(2)
•••
Pascalbios
X
View Profile
View Bullboard History
Post by
Pascalbios
on Apr 26, 2021 10:25am
PASCAL BIOSCIENCES TO PRESENT AT CANNABINOID DERIVED PHARMAC
Pascal Biosciences, Inc. ("Pascal" or the "Company") (TSXV:PAS)(OTC PINK:BIMUF), will present at the firstCannabinoid Derived Pharmaceuticals Industry Review Summit today. Dr
...more
(2)
•••
Pascalbios
X
View Profile
View Bullboard History
Post by
Pascalbios
on Apr 26, 2021 8:52am
> PAS-393 for Cancer <
Cannabinoid-based therapeutic for restoring immune recognition Advanced cancers typically become invisible to the immune system, thus allowing them to evade elimination. PAS-393 is a cannabinoid
...more
(2)
•••
Pascalbios
X
View Profile
View Bullboard History
Post by
Pascalbios
on Apr 26, 2021 8:51am
> PAS-403 for Glioblastoma <
Cannabinoid-based therapeutic for glioblastoma PAS-403 (previously known as ST-403) is a mitosis inhibitor that blocks cell division. The cannabinoid-based product is undergoing development for the
...more
(2)
•••
Pascalbios
X
View Profile
View Bullboard History
Post by
Pascalbios
on Apr 26, 2021 8:22am
> Cannabinoid therapeutic for treating COVID-19 <
The coronavirus pandemic has triggered a massive, worldwide effort to develop effective vaccines and treatments. With a previous focus on cancer, Pascal’s scientists directed their efforts to
...more
(2)
•••
Pascalbios
X
View Profile
View Bullboard History
Post by
Pascalbios
on Apr 25, 2021 8:09pm
> Cannabinoids in Medicine <
Cannabinoids can be categorized into three main groups: endocannabinoids, phytocannabinoids, and synthetic cannabinoids. Endocannabinoids are the hormone-like messengers of the mammalian
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Introducing the NEW DealRoom: Your Gateway to Capital-Raising Investments